Select Committee on Health Written Evidence


APPENDIX 10

Memorandum by The Technical Solutions Implementation Group of the UK e-Health Association (MT 41)

UK E -HEALTH ASSOCIATION

  The UK e-Health Association is a membership body representing those organisations and individuals interested in promoting e-health in the United Kingdom. It is a non-profit making company limited by guarantee governed by a Board of Trustees. It counts among its members organisations and individuals from both private and public sectors. Further information about UKeHA may be found on its website (www.ukeha.org.uk).

  This evidence has been prepared by members of the UKeHA Technical Solutions Implementation Group (TSIG) and approved by the UKeHA Board.

  The UKeHA and TSIG would be pleased to submit oral evidence, if required.

RECOMMENDATIONS

  1.  The Department of Health should provide active top level leadership for the development of e-health services and should more effectively coordinate existing and new e-health activities across the health sector; and to this end should designate an "e-health leader" at the most senior level (outwith the National Programme for IT).

  2.  There is a need for a showcase for new technologies, systems and services, in use on a day to day basis, designed to allow evaluation and appraisal of new developments based on experience and their relative value as part of a wider, overall solution.

  3.  Such evaluation should also cover the technical capabilities of new technologies and systems, with support from appropriately qualified medical technicians and IT specialists. Clear information should be produced on the capabilities and limitations of the systems in different environments, how and where they could be used, and interface with other systems.

  4.  Such evaluation should also cover the people and process aspects of new technologies, to develop "standard operating procedures" to ensure the seamless integration and interoperation of the specific device, system or service, irrespective of its place of use or the place of service delivery.

  5.  e-health systems and services subject to such evaluation should be accredited such that any accredited system or service should be able to integrate and interoperate with any other accredited system or service anywhere else in the country.

  6.  Recommendations 2-5 above could be achieved within the context of an "Incubation Centre" where innovations are used and tested in real working situations. Within such a centre the relevance to and capabilities of integration and interoperation with other systems could be evaluated and an appropriate blue print of how they should be used in other real world situations defined. The "Incubation Centre" would not be just a showcase but a model of how innovative technologies could be used.

INTRODUCTION

  1.  This report looks at the use of new medical technologies from an e-health perspective. e-health, as with e-commerce and e-government, relates to all aspects of health that utilise electronic processing, communication, storage etc. Given the prevalence of such matters in all walks of life, one would think that this would be a principle concern of any initiative concerned with improving health or developing healthcare services. Unfortunately, e-health is usually an afterthought, and new technologies are more usually developed in isolation, instead as part of an integrated and interoperating network of care services.

E -HEALTH AND NPFIT

  2.  We understand that the Health Committee's Inquiry does not extend to the National Programme for Information Technology (NPfIT). It is however important to understand that e-health extends much wider than NPfIT—indeed NPfIT can be regarded as a relatively narrow programme of infrastructure development, which in due course may well enable much wider e-health development. In the short term there is a danger that the very significant investment in NPfIT and the consequent prominence given to it in the management and funding of the NHS will overshadow and suppress the need for wider e-health development. There is a real danger of missed opportunity through the lack of clear leadership from the centre on e-health development and the coordination of existing e-health activity.

  3.  This is why our first recommendation is concerned with the need for much more active top-level leadership by the Department of Health on the development of e-health.

THE UTILISATION OF TELEMEDICINE (INCLUDING TELECARE) AND ITS FUTURE POTENTIAL FOR IMPROVING SERVICES

  4.  New technology within medicine is a subject as old as medicine itself and as in any walk of life, is always looked on with scepticism and introduced with reservation. The stethoscope is a particularly good example of such initial scepticism. It is, however, in the area of computerisation that the biggest problems arise. This is best understood by looking at the history of computers in health. Initially computers delivered little or no clinical benefit but did increase the workload on clinicians and were a long way from being "user friendly". The advent of the PC and more specifically, sophisticated operating systems such as Windows, helped dramatically by being more useable and offering easier access to information. However, a whole plethora of dissimilar competing systems were developed with individual clinicians exercising personal preferences for this or that system. They did not (and still do not) integrate or interoperate with one another and they do not necessarily collect the same data. While much of this is the responsibility of NPfIT (and therefore outside the scope of this Inquiry) there are important aspects that are not covered and it is these that we now examine.

  5.  Most measurements of physiological data by clinicians, such as blood pressure, are done manually or by stand-alone devices. Transcribing this information into a patient's record is also done manually, even when using a computerised electronic patient record system. These electronic devices are obviously more prevalent in hospitals and ambulances. Some even have a data port, which will allow them to connect to another electronic device or link them into a larger, proprietary system. There are two significant problems with this, firstly, they are designed as stand alone systems not as components of an integrated information system and secondly, there is much confusion about what they can or cannot do.

  6.  An illustration may help. The government has recently made money available to ambulance services to purchase "telemedicine" enabled 12 lead Electrocardiograph (ECG) units (An ECG unit is a device for producing a graph of the electrical activity of the heart. The term "lead" refers to a view of the heart through a particular axis). What is a 12 lead ECG? Do we really need a 12 lead or would a 3 lead do? (A 12 lead is used routinely in hospital both because it is available and because it usually gives diagnostic details without the need for a cardiologist). If we do need a 12 lead, do we need all 12 leads simultaneously or one at a time? If one at a time should they all be of the same time interval, sent sequentially, or a representation of the time interval over which they are being sent? How are we going to send it? Who is going to receive it and what will happen to it then?

  7.  These questions serve to remind us that devices themselves are not a solution, in fact most devices on their own have little diagnostic value, and there are other components necessary to ensure that they work as part of a solution that at least allows access to an appropriately qualified person to use/interpret the data received.

  8.  It is also important to realise that the fact that a 12 lead ECG unit has a data port and is "communications enabled" does not make it a telemedicine unit. Telemedicine requires appropriate data communication and trained personnel. And what does "communications enabled" mean? Often it means that it can communicate with a computer, which is also potentially very misleading. Those with PC experience you will know that even if everything works correctly now, if you try and install a new program or device, while it may or may not work, other applications and systems that were previously working may now not work! This is not an acceptable outcome for a medical device. There is a serious lack of understanding, outside the regulatory bodies, about the use of computers in the medical field and about what is and what is not a medical device and where responsibility for failure lies.

  9.  Companies that produce these devices sometimes also produce a range of other devices that link together to make a total "solution". While this overcomes the problem of a "stand-alone" device, it does create an additional problem that you have to use their components, their terminals, their software etc. This is how the computer market was before the advent of the IBM Personal Computer (PC) 25 years ago. Nowadays you can buy any PC software and it will run, any hardware and it will connect. You can take data off your PC and run it on someone else's.

  10.  We take this interconnectivity for granted, and businesses have grown up that only make certain bits of computer hardware. Perhaps less well known is the fact that specialist programmers write pieces of code which are used by other programmers to incorporate into their own offerings. Before the "PC" this could not be done. Not only could you not take a floppy disk from one computer and run it on another, the disk probably wouldn't even fit. Programmers not only had to write programs for specific makes of computer but they might also have to restrict users to a set of known printers and other peripherals.

  11.  Just as the PC market changed, so too must the medical market. For the PC this was brought about by an open hardware platform (the IBM Personal Computer or "PC") and a common operating system or user interface. The medical market must change in a similar way but with one important additional item, the adoption of common practices and standard clinical procedures on a national basis. This is nothing to do with clinical or regulatory standards, which are already well catered for, but a clear set of "Standard Operating Procedures" to ensure different people in separate locations know what is going on, where in a process things are and what comes next.

  12.  Most professions have clearly defined rules and procedures, and as circumstances change then the rules change. Medicine is practised by highly qualified professionals but (and this is really serious) they practice medicine in their own particular way. Imagine if this was how air traffic control was handled. With the advent of e-health, many clinical interventions will be done without the physical presence of a clinician, or by a less qualified clinician remotely supported. For this to work smoothly there need to be clearly defined operational procedures and processes. We are not referring to aspects already adequately covered by existing standards bodies and agencies but the specific elements that pertain to remote use and the interaction and interoperability of people and systems when connected electronically.

  13.  As has already been mentioned, the term "Telemedicine" now comes under the broader banner of e-health, along with Telecare. However, the intended focus of this Inquiry is presumed to be the use of e-health systems and services to deliver remote medical interventions (telemedicine) and ongoing remote care at home or other non-medical facilities (telecare). The key word here is "remote", which simply means that one or more elements of the solution are not at the same locality as the patient. Remote can, therefore, be as diverse as the care of an airline passenger by a doctor on the ground or a patient receiving care at home from a community nurse with remote access to patient records, hospital booking systems etc. Large distances are NOT a prerequisite!

  14.  At the moment, instances of telemedicine and telecare tend to be looked at in isolation, a bit like looking at flour, eggs, sugar etc as the end product without looking to see how these things can be put together to make something that is more than the sum of the parts. Indeed, very little consideration is given to telemedicine despite the huge cost being incurred in building NPfIT, which will enable telemedicine and turn it into a major form of medical intervention.

  15.  NHS Direct is telemedicine, in the sense that the initial activity is telephone based (and therefore remote). Despite doing a reasonable job for many, it does a less than adequate job for most long term or repeat illness patients, who need an enhanced system where they reach a clinician with direct access to their notes and, in the case of longer term illness, perhaps even real time medical parameters, blood pressure, ECG etc. It is not that the capability does not exist to provide such enhanced service; it is just that there is no high level support for such initiatives.

  16.  Instances of telemedicine and telecare are currently run as local "pilots" where there is a clinical lead that is willing to support the initiative. Often funding for such "pilots" dries up or the clinical lead moves on. This lack of high-level support means that the same initiatives are piloted again and again all over the country, the outcomes of previous pilots being completely unknown to anyone other than those intimately involved in the project.

  17.  There is also a sense that telemedicine systems, because they connect to computer systems, which are getting cheaper and cheaper, should also be significantly cheaper than hospital systems. An over the counter blood pressure unit from Boots can cost you less than a hundred pounds, while a hospital unit often costs 10 times this. The answer is clearly one of quality, but as more and more of these systems are produced their unit cost will reduce. What we shouldn't do, but is happening, is to compare telemedicine systems based on low quality components, with the equivalent high quality hospital based system.

  18.  Once we make this change of attitude, the potential for telemedicine far exceeds our imagination. Care homes are, by their very nature, places that tend to have a greater need for home visits and out of hours care. By putting telemedicine equipment into these locations and connecting them to a "virtual GP" system, much of this need could be addressed remotely. Community nurses should also be equipped with appropriate systems both in terms of monitoring and remote access to electronic patient records, decision support tools and so on. Once established, with the staff and patients both conversant with the systems, it will be possible for regular, routine monitoring to take place, not just knee jerk emergency intervention. Regular monitoring combined with other pieces of relevant information can be used for early intervention and ultimately prevention.

  19.  Telemedicine is not simply about technology, it requires the adoption of common practices and processes. This cannot be achieved by individual "pilots" run by local enthusiasts; this must be done, first in a specific area (where it is evaluated and problems ironed out) and then systematically on a wider and wider basis until adopted nationwide. This requires support at the highest level within government and, on an International basis, through cooperation and mutual development with other countries.

  20.  Telemedicine will also enable a strong interaction between the private sector and NHS. There is a diving company, based in Aberdeen, which provides telemedicine support for their divers, even while still in hyperbaric chambers. A doctor, also in Aberdeen, is able to monitor a diver, under pressure in a hyperbaric chamber, on board the company's diving vessels, wherever they may be, anywhere in the world. Under the NPfIT, these divers will all have an electronic patient record; the private doctor in Aberdeen should be allowed appropriate access to this record to be able to properly manage the current medical situation. Likewise, on returning to shore, the diver's GP should be able to see what action was taken by the doctor in Aberdeen and by any medic on the ship. This is just one example of how companies and even individuals will pay for medical services, the outcome of which is available to NHS doctors, thereby simplifying and streamlining the interventions and care given and ultimately reducing costs through cutting out duplication of tests etc.

  21.  Ultimately, people will be able to receive hospital grade monitoring in their workplace, at the gym, on board an aircraft on holiday and so on. These cease to be isolated incidents but part of the complete picture of a person's long-term health.

THE RECOMMENDATIONS OF THE HEALTHCARE INDUSTRIES TASK FORCE (HITF) REPORT, PUBLISHED 17 NOVEMBER 2004

  22.  The main recommendations of the HITF report were contained in nine key outputs; however, these are primarily concerned with medicine as we know it, not e-health, which is seen as a new technology in itself. It is our belief that, within a very short time frame, all aspects of health will, in some way, integrate with a wider "e" component, even if they are not themselves part of an overall e-health solution. To that end, this report emphasises the additional aspects needed for this to happen.

  23.  The HITF report seeks to "inform procurement decisions and encourage the support and uptake of useful, safe, innovative products and procedures". For this to happen, there must be some system of evaluation and assessment that has also been proven in real life scenarios. The UKeHA TSIG has already produced various documents on how this should be done and welcomes the recommendations of the report. Unfortunately, unless these recommendations are followed through, nothing changes. There is also the need to "train the trainers" with regard to the wider benefits of e-health. While the outputs of the HITF are being considered and the follow-on actions devised, e-health implications must be built in. Otherwise technology will only be an add-on to existing practices, not an integral part of healthcare delivery.

  24.  The report also seeks to "Stimulate more innovation and encourage a more entrepreneurial culture in industry and the NHS". The only part of this that needs serious action is that part involving the NHS and even here it is not a lack of desire on the part of those involved, simply those in decision making positions. The UK leads the world in the development of innovative medical technology; the problem is not one of innovation but one of innovative leadership.

  25.  The HITF report calls for a new Innovation Centre, and while this is a good idea in principle, what we really need is an "Incubation Centre" (see our Recommendations) where innovations are used and tested in real, working situations. Within such a centre the relevance to and capabilities of integration and interoperation with other systems can be evaluated and an appropriate blue print of how they should be used in other real world situations defined. The "Incubation Centre" would not be just a showcase but a model of how innovative technologies can be used. Nurses need to see other nurses working with something to understand the true potential and value; the same is true of all professionals, not just in healthcare. Such a centre would also fulfil a large number of other recommendations of the HITF report, with the exception of introducing an "innovation fund". However, the output of the "Incubation Centre" will do this and the need therefore is not for a "fund" but to fund the "Incubation Centre".

  26.  One aspect looked at in the HITF report is procurement. It is not for us to make recommendations outside our sphere of expertise. However, common sense would suggest that if an "Incubation Centre" is established and it delivers clear guidelines on not only how to use a specific piece of technology for a particular function, but defines best practice procedures and processes, then healthcare agencies within the NHS should, subject to their own budgetary constraints, be able to purchase said technology for use in this manner. Those involved in the procurement process should actively work with the "Incubation Centre" to ensure that "cost effectiveness" is a major consideration and provide details of how this is evaluated.

  27.  e-health also has a serious role to play in providing the evidence base in support of R&D activities. Regular monitoring of everyone, by using e-health tools as part of an overall e-health programme, will provide a greater understanding of factors leading to ill health. At the moment people only really enter an evidence-based program once they are already sick. e-health offers the first real chance of monitoring people, both well and sick, from before birth until death and should, therefore, be embraced as a common thread to any R&D programme.

  28.  The UKeHA is aware of a number of initiatives involving different academic centres of excellence, which are looking to be "the recognised academic body" within a specific area or aspect of health. The UKeHA and its TSIG would be happy to work with any academic institute to this end and already has strong representation from a number of academic bodies as members. The key would be for the academics to work with the "Incubation Centre", as outlined above, to ensure that all are working to the same goals.

  29.  The establishment of an "Incubator Centre" would also provide a platform from which to address communications with and between patients/the public and clinical bodies/government agencies in all aspects relating to e-health. A working centre that is open to public scrutiny and which would actively encourage the participation of patient and healthcare groups, including Royal Colleges, Unions and other interested parties, would provide an open forum that would actively encourage communication. This, in turn leads to education and training.

  30.  "Knowledge dispels fear" is an apt phrase because the converse is also true. People are afraid of what they do not understand. When PCs were first introduced, people from all walks of life became concerned about their jobs and a myriad of other completely unrelated things. Training and education removes this barrier of fear and people move on.

  31.  The HITF report suggests "Maximising UK influence in regulatory matters in the EU and other international forums". We agree with this wholeheartedly, the UK already leads the world in many aspects of e-health and to apply best practice and standard operating procedures to this at a time when they simply do not exist would be to secure our long-term influence. This is also a major cost factor as, if other standards are adopted in preference to ours, then in order to operate on an international basis, our systems will have to be changed or adapted to meet these different standards.

THE SPEED OF, AND BARRIERS TO, THE INTRODUCTION OF NEW TECHNOLOGIES

  32.  It is fair to say that most e-health "pilots" have not moved beyond the initial "pilot" stage. The reasons for this have been well documented: principally they have been driven by a single, local, sponsor with no ongoing funding and no "place" for a full blown service within the current healthcare structure.

  33.  Healthcare is broken up into very distinct compartments and if an initiative crosses boundaries, or worse if the benefits of an initiative are seen in a different sectors, there is no funding. Sources of funding also change, and even when funding has been obtained, it is not unknown for this to be used somewhere else or for a different purpose within an organisation.

  34.  There is little to no long term planning, with short-term goals taking precedence over long term objectives that could otherwise bring accumulating benefits.

  35.  There is a lack of trust by clinicians in IT systems, which have, in the past, been purely administrative tools. There needs to be a place where people from all sectors of healthcare can go and see new technology being used in real situations by ordinary people.

THE EFFECTIVENESS AND COST BENEFIT OF NEW TECHNOLOGIES

  36.  As new technologies, practices and processes are adopted, there will be the initial benefits for which they were intended, but there will then come additional benefits, many of which will remain unknown until they actually happen. What we have to be wary of, however, is a simplified comparison against some arbitrary factor.

  37.  By way of illustration, there was a dermatology pilot conducted between GPs in rural practices and a remote consultant dermatologist. When the GPs were faced with a skin problem they could not identify, an appointment would be made for the patient to return to the practice at a time when the doctor could have a live link to the remote dermatologist. The skin would be photographed using an appropriate digital camera and the image sent to the dermatologist. He would discuss this with the patient in the presence of the GP.

  38.  At the end of the project it was reported to be a failure, not by the doctors, patients or dermatologist but by a third party auditor. The reason for the failure was that, after an initial period of regular use, the system was used less and less. On questioning the doctors, they deemed it a huge success. Why the drop in usage? Each time they referred a patient, they were, in effect, receiving ongoing training. Once a condition had been seen on a number of occasions, the doctors no longer needed to refer the patient but were able to deal with the situation themselves!

  39.  Healthcare will never cost less, but, it will be possible to do more for the same amount. As new technologies emerge, when a patient is screened for one particular aspect, it will probably be possible to simultaneously screen for many other things at the same time. If e-health is taken seriously and the right sort of leadership provided, medicine will start to move from only dealing with people once they are sick, to managing them while they are well and intervening at the fist sign of "preconditions" to act in a preventative manner. Healthcare in the UK will move to a truly National HEALTH Service.





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 15 April 2005